Immunogenicity of a Mammalian Cell-derived Recombinant Hepatitis B Vaccine Containing Pre S2 and Pre S1 Antigens: A Preliminary Report

This publication has 12 references indexed in Scilit:

• Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein—a preliminary study on immunogenicity
  Vaccine, 1992
• Protective potential of hepatitis B virus antigens other than the S gene protein
  Vaccine, 1990
• Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine
  Vaccine, 1990
• T- and B-cell recognition of hepatitis B viral antigens
  Immunology Today, 1988
• ANTIBODY RESPONSE TO PRE-S2 AND HEPATITIS B VIRUS INDUCED LIVER DAMAGE
  The Lancet, 1988
• A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.
  Proceedings of the National Academy of Sciences, 1986
• Antibodies to a synthetic peptide from the preS 120–145 region of the hepatitis B virus envelope are virus-neutralizing
  Vaccine, 1986
• Enhanced Immunogenicity of the Pre-S Region of Hepatitis B Surface Antigen
  Science, 1985
• Human hepatitis B vaccine from recombinant yeast
  Nature, 1984
• A controlled clinical trial of the efficacy of the hepatitis B vaccine (heptavax B): A final report
  Hepatology, 1981